Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Indian panel wants Johnson & Johnson to pay compensation over recalled implants

A government panel recommended that Johnson & Johnson pay compensation of at least $28,500 to each Indian patient who suffered from artificial hip implants the U.S. healthcare firm recalled eight years ago.

Read More »

Novartis says glaucoma stent setback will not derail Alcon spin-off

Novartis’ eye care unit Alcon is withdrawing a surgical stent for glaucoma patients after clinical data showed it may damage the eye, but the Swiss drugmaker said the move would not affect plans to spin off the unit 2019.

Read More »

AstraZeneca inhaler lags GSK drug in lung disease trial

A new AstraZeneca inhaler for chronic lung disease proved worse than a rival GlaxoSmithKline product in a clinical trial.

Read More »

FDA Clears SPR Therapeutics’ Non-Opioid Neurostimulation Pain Therapies

The U.S. Food and Drug Administration cleared Cleveland-based SPR Therapeutics’ SPRING endura (single lead) and extensa (dual lead) Peripheral Nerve Stimulation Systems for controlling pain.

Read More »

Pharma Innovators Special Feature 2018: Focus on innovation

In seeking innovative players that could change pharma and healthcare, Med Ad News found the developer of an app that helps people determine what illnesses are in their neighborhoods; the creator of a wearable injector that allows patients on biologics to receive these drugs outside the clinic; and a designer of a deep learning network aimed at giving pharma and healthcare companies a handle on their data.

Read More »

FCB Health Network’s 2018 Next: Innovation Week conference

For the second year, FCB Health Network brought together a stellar group of experts to showcase the latest offerings in virtual and augmented reality, social media, technology, hardware, artificial intelligence, cloud computing services, data visualization, design, and more for its Next: Innovation Week series.

Read More »

Boston Scientific Continues M&A Spree

Boston Scientific Corp. forked over up to $160 million to acquire California stent maker Veniti Inc. The deal marks the third acquisition for Boston Scientific in two months.

Read More »

Breast Cancer Device Receives FDA Approval

The U.S. Food and Drug Administration approved the first non-radioactive, dual-tracer for sentinel lymph node biopsy.

Read More »

Bayer hits back at new Netflix medical device documentary

Bayer AG disputed accusations in a new Netflix documentary that claims medical device makers and the U.S. Food and Drug Administration placed profits before patient safety.

Read More »

U.S. House Votes to Repeal Medical Device Tax, Goes Before Senate

After multiple suspensions, the U.S. House of Representatives overwhelmingly voted to repeal a 2.3 percent tax on medical devices which is part of the Affordable Care Act that industry representatives believes has stifled innovation.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

April 2019 Focus: Healthcare agency & network profiles, industry overview & awards, and more!

Subscribe

Ad Right Bottom